CLYYF
Price
$0.53
Change
+$0.03 (+6.00%)
Updated
Jul 28 closing price
Capitalization
18.86M
SIGY
Price
$2.80
Change
+$0.05 (+1.82%)
Updated
Jul 11 closing price
Capitalization
4.5M
Interact to see
Advertisement

CLYYF vs SIGY

Header iconCLYYF vs SIGY Comparison
Open Charts CLYYF vs SIGYBanner chart's image
Celyad Oncology SA
Price$0.53
Change+$0.03 (+6.00%)
Volume$999
Capitalization18.86M
Sigyn Therapeutics
Price$2.80
Change+$0.05 (+1.82%)
Volume$227
Capitalization4.5M
CLYYF vs SIGY Comparison Chart in %
Loading...
CLYYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLYYF vs. SIGY commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYYF is a Hold and SIGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (CLYYF: $0.53 vs. SIGY: $2.80)
Brand notoriety: CLYYF and SIGY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYYF: 210% vs. SIGY: 20%
Market capitalization -- CLYYF: $18.86M vs. SIGY: $4.5M
CLYYF [@Biotechnology] is valued at $18.86M. SIGY’s [@Biotechnology] market capitalization is $4.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYYF’s FA Score shows that 0 FA rating(s) are green whileSIGY’s FA Score has 0 green FA rating(s).

  • CLYYF’s FA Score: 0 green, 5 red.
  • SIGY’s FA Score: 0 green, 5 red.
According to our system of comparison, CLYYF is a better buy in the long-term than SIGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYYF’s TA Score shows that 2 TA indicator(s) are bullish while SIGY’s TA Score has 4 bullish TA indicator(s).

  • CLYYF’s TA Score: 2 bullish, 2 bearish.
  • SIGY’s TA Score: 4 bullish, 0 bearish.
According to our system of comparison, SIGY is a better buy in the short-term than CLYYF.

Price Growth

CLYYF (@Biotechnology) experienced а 0.00% price change this week, while SIGY (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLYYF($18.9M) has a higher market cap than SIGY($4.5M). CLYYF YTD gains are higher at: 116.327 vs. SIGY (-11.111).
CLYYFSIGYCLYYF / SIGY
Capitalization18.9M4.5M420%
EBITDAN/A-2.39M-
Gain YTD116.327-11.111-1,047%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A12.9K-
Total DebtN/A2.51M-
FUNDAMENTALS RATINGS
CLYYF vs SIGY: Fundamental Ratings
CLYYF
SIGY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
4864
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
1775

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLYYF's Valuation (81) in the null industry is in the same range as SIGY (85). This means that CLYYF’s stock grew similarly to SIGY’s over the last 12 months.

CLYYF's Profit vs Risk Rating (100) in the null industry is in the same range as SIGY (100). This means that CLYYF’s stock grew similarly to SIGY’s over the last 12 months.

CLYYF's SMR Rating (99) in the null industry is in the same range as SIGY (100). This means that CLYYF’s stock grew similarly to SIGY’s over the last 12 months.

CLYYF's Price Growth Rating (48) in the null industry is in the same range as SIGY (64). This means that CLYYF’s stock grew similarly to SIGY’s over the last 12 months.

SIGY's P/E Growth Rating (98) in the null industry is in the same range as CLYYF (100). This means that SIGY’s stock grew similarly to CLYYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLYYFSIGY
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
50%
Bullish Trend 4 days ago
66%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
12%
Bullish Trend 4 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
9%
Bullish Trend 4 days ago
53%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
CLYYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONTTF2.840.06
+2.01%
Oxford Nanopore Technologies PLC
WHGLY20.770.20
+0.97%
WH Group Ltd.
CMVLF3.12N/A
N/A
Cellectis Romainville
BMKDF0.25N/A
N/A
Biomark Diagnostics Inc.
SRKE0.18N/A
N/A
Strake Inc.

CLYYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYYF has been loosely correlated with ELVAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYYF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYYF
1D Price
Change %
CLYYF100%
N/A
ELVAF - CLYYF
47%
Loosely correlated
N/A
WHWK - CLYYF
37%
Loosely correlated
-2.78%
HLVX - CLYYF
26%
Poorly correlated
+0.24%
REPL - CLYYF
25%
Poorly correlated
N/A
WXXWY - CLYYF
25%
Poorly correlated
-2.22%
More

SIGY and

Correlation & Price change

A.I.dvisor tells us that SIGY and ELVAF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and ELVAF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
N/A
ELVAF - SIGY
31%
Poorly correlated
N/A
IVVD - SIGY
20%
Poorly correlated
+5.88%
CLYYF - SIGY
12%
Poorly correlated
N/A
NBTX - SIGY
11%
Poorly correlated
+2.64%
CPMV - SIGY
6%
Poorly correlated
N/A
More